BIO-TECH AS
Operating
Utvikling og markedsføring av produkter og
tjenester for helsesektoren og beslektede
områder, herunder deltagelse ved utlån og
kjøp av aksjer/andeler.
Organization
- Chairman of the board
- KE
- Years since formation
- 31 years
- since Feb 19, 1995
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 100,000
- 1 share class
- Total number of shareholders
- 1
- person
Financials
- Total operating income 2025
- 93,000
- NOK
- Annual total result 2025
- 1,903,711
- NOK
- Total equity 2025
- 12,162,621
- NOK
Last update: Apr 23, 2026
Management
Board
| Name | Role | Shares |
|---|---|---|
KE | Chairman | 100 % directly |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
KE | Chairman | 100 % directly |
Last update: Apr 13, 2023
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
KE | Ordinary shares | 100,000 | 100 % |
Shares owned by the BIO-TECH AS
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 1,135 | 0.13 % | |
| Ordinary shares | 190,885 | 0.07 % | |
| Ordinary shares | 164,057 | 0.04 % | |
| Ordinary shares | 87,656 | 0.02 % | |
| Ordinary shares | 69,945 | 0.02 % | |
| Ordinary shares | 44,000 | 0.02 % | |
| Ordinary shares | 6,500 | < 0.01 % | |
| Ordinary shares | 6,482 | < 0.01 % | |
| Ordinary shares | 1,000 | < 0.01 % | |
| Ordinary shares | 3,890 | < 0.01 % | |
| Ordinary shares | 16,000 | < 0.01 % | |
| Ordinary shares | 11,000 | < 0.01 % | |
| Ordinary shares | 4,000 | < 0.01 % | |
| Ordinary shares | 14,792 | < 0.01 % | |
| Ordinary shares | 40,000 | < 0.01 % | |
| Ordinary shares | 775 | < 0.01 % |
Last update: Sep 25, 2026
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total operating income | 93,000 | 90,000 | 84,000 | 84,000 |
Annual Total Result | 1,903,711 | 1,450,888 | -1,011,817 | -3,929,268 |
Total assets | 12,191,205 | 10,568,475 | 9,620,346 | 10,645,935 |
Total liabilities | 28,584 | 309,565 | 512,324 | 526,095 |
Total equity | 12,162,621 | 10,258,910 | 9,108,022 | 10,119,840 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total operating income | 93,000 | 90,000 | 84,000 | 84,000 |
Total operating costs | 95,334 | 76,406 | 70,766 | 76,200 |
Operating result | -2,334 | 13,594 | 13,234 | 7,800 |
Financial income/costs | 1,913,503 | 1,446,858 | -1,020,247 | -3,933,467 |
Profit before tax | 1,911,169 | 1,460,453 | -1,007,012 | -3,925,667 |
Total tax & extraordinary income/cost | 7,458 | 9,565 | 4,805 | 3,601 |
Annual Total Result | 1,903,711 | 1,450,888 | -1,011,817 | -3,929,268 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total fixed assets | 1,250,000 | 1,250,000 | 1,250,000 | 1,250,000 |
Total current assets | 10,941,205 | 9,318,475 | 8,370,346 | 9,395,935 |
Total assets | 12,191,205 | 10,568,475 | 9,620,346 | 10,645,935 |
Short term debt | 7,458 | 9,565 | 4,805 | 3,601 |
Long term debt | 21,126 | 300,000 | 507,519 | 522,494 |
Total liabilities | 28,584 | 309,565 | 512,324 | 526,095 |
Contributed capital | 2,010,800 | 2,010,800 | 2,010,800 | 2,010,800 |
Retained earnings | 10,151,821 | 8,248,110 | 7,097,222 | 8,109,040 |
Total equity | 12,162,621 | 10,258,910 | 9,108,022 | 10,119,840 |
Total equity and liabilities | 12,191,205 | 10,568,475 | 9,620,346 | 10,645,935 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification